Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
---|---|---|---|---|---|---|
Q2 2024 | 65 | 3,915,263 | T, VZ, SGOV, WFC | 13F-HR | 8/7/2024 | 000108514624003573 |
Q1 2024 | 63 | 3,997,610 | VZ, SGOV, T, WFC | 13F-HR | 5/6/2024 | 000108514624002283 |
Q4 2023 | 60 | 3,559,968 | VZ, T, SGOV, WFC | 13F-HR | 2/8/2024 | 000108514624000904 |
Q3 2023 | 59 | 3,213,062 | SGOV, T, GSKN.MX, VZ | 13F-HR | 11/7/2023 | 000108514623004179 |
Q2 2023 | 60 | 3,231,633 | SGOV, VZ, GSKN.MX, WFC | 13F-HR | 8/2/2023 | 000108514623003039 |
Q1 2023 | 57 | 3,050,777 | T, VZ, GSKN.MX, INGR | 13F-HR | 5/3/2023 | 000108514623002040 |
Q4 2022 | 56 | 2,972,858 | T, TOT, VZ, INGR | 13F-HR | 2/7/2023 | 000108514623000767 |
Q3 2022 | 53 | 2,607,490 | T, GL, WFC, TOT | 13F-HR | 11/9/2022 | 000108514622003864 |
Q2 2022 | 56 | 2,700,859 | GSK, T, VZ, TOT | 13F-HR | 8/8/2022 | 000108514622002880 |
Q1 2022 | 59 | 2,929,275 | T, GSK, VZ, WMB | 13F-HR | 5/10/2022 | 000108514622001928 |
Q4 2021 | 54 | 2,762,831 | GSK, DLTR, VZ, WFC | 13F-HR | 2/7/2022 | 000108514622000593 |
Q3 2021 | 53 | 2,608,663 | GSK, VZ, WFC, GD | 13F-HR | 11/15/2021 | 000108514621003271 |
Q2 2021 | 53 | 2,656,041 | GSK, VZ, WFC, WMB | 13F-HR | 8/6/2021 | 000108514621002261 |
Q1 2021 | 52 | 2,515,392 | VZ, GSK, HIG, WFC | 13F-HR | 5/12/2021 | 000108514621001591 |
Q4 2020 | 51 | 2,144,226 | SCHW, GSK, VZ, HIG | 13F-HR | 2/10/2021 | 000108514621000561 |
Q3 2020 | 52 | 1,964,951 | UPS, VZ, JNJ, GSK | 13F-HR | 11/12/2020 | 000108514620002896 |
Q2 2020 | 50 | 2,013,075 | VZ, UPS, GSK, TFC | 13F-HR | 8/10/2020 | 000108514620002080 |
Q1 2020 | 49 | 1,938,193 | VZ, UPS, JNJ, GSK | 13F-HR | 5/11/2020 | 000108514620001399 |
Q4 2019 | 53 | 2,908,669 | SHV, GSK, USB, UPS | 13F-HR | 2/11/2020 | 000108514620000576 |
Q3 2019 | 47 | 2,801,208 | SHV, UPS, GSK, USB | 13F-HR | 11/12/2019 | 000108514619002828 |
Q2 2019 | 62 | 2,864,440 | SHV, EBAY, USB, GSK | 13F-HR | 8/5/2019 | 000108514619002068 |
Q1 2019 | 60 | 2,963,137 | SHV, GSK, UPS, XOM | 13F-HR | 5/7/2019 | 000108514619001384 |
Q4 2018 | 65 | 2,772,932 | SHV, VZ, GSK, USB | 13F-HR | 2/13/2019 | 000108514619000604 |
Q3 2018 | 61 | 3,098,887 | SHV, XOM, GSK, TGT | 13F-HR | 11/5/2018 | 000108514618002490 |
Q2 2018 | 56 | 3,076,756 | SHV, EXC, XOM, GSK | 13F-HR | 8/3/2018 | 000108514618001819 |
Q1 2018 | 57 | 3,014,158 | SHV, GSK, EXC, XOM | 13F-HR | 5/7/2018 | 000108514618001251 |
Q4 2017 | 58 | 3,002,421 | EXC, EBAY, AXP, TGT | 13F-HR | 2/12/2018 | 000108514618000558 |
Q3 2017 | 53 | 2,898,373 | EBAY, WMT, EXC, AXP | 13F-HR | 11/13/2017 | 000108514617002272 |
Q2 2017 | 46 | 2,926,472 | WMT, EXC, EBAY, MDT | 13F-HR | 8/4/2017 | 000108514617001642 |
Q1 2017 | 40 | 3,071,150 | EBAY, EXC, WMT, XOM | 13F-HR | 5/9/2017 | 000108514617001142 |
Q4 2016 | 42 | 3,108,541 | WMT, EXC, PEP, XOM | 13F-HR | 2/2/2017 | 000108514617000250 |